

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.93213479 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.89623108 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.68799591 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.68799591 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 5.59550884 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88612803 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.67060199 |
| 8 | negative T cell selection (GO:0043383) | 4.54610977 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.43791990 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.22320618 |
| 11 | detection of other organism (GO:0098543) | 4.20852334 |
| 12 | detection of bacterium (GO:0016045) | 4.20180475 |
| 13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.18104253 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.12890757 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12731493 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07617912 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.04751411 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.02820817 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.00676475 |
| 20 | myeloid dendritic cell differentiation (GO:0043011) | 3.99885210 |
| 21 | myeloid dendritic cell activation (GO:0001773) | 3.98848917 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.97831204 |
| 23 | negative regulation of cell killing (GO:0031342) | 3.94903700 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.94903700 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.94668036 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.90833533 |
| 27 | neutrophil activation (GO:0042119) | 3.89697459 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.87619744 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.84610095 |
| 30 | leukocyte aggregation (GO:0070486) | 3.82235650 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.80209527 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.78061571 |
| 33 | cellular extravasation (GO:0045123) | 3.73320887 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.73035952 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.72561688 |
| 36 | granulocyte activation (GO:0036230) | 3.68814199 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.64815420 |
| 38 | positive regulation of interleukin-2 production (GO:0032743) | 3.64815095 |
| 39 | thymic T cell selection (GO:0045061) | 3.63476173 |
| 40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58269096 |
| 41 | response to peptidoglycan (GO:0032494) | 3.56840267 |
| 42 | response to type I interferon (GO:0034340) | 3.56524943 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.56070065 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.55229762 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.55229762 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.55183549 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.53974278 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.48819886 |
| 49 | T cell selection (GO:0045058) | 3.48176454 |
| 50 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.47678975 |
| 51 | natural killer cell mediated immunity (GO:0002228) | 3.47678975 |
| 52 | positive regulation of humoral immune response (GO:0002922) | 3.45718988 |
| 53 | cellular response to zinc ion (GO:0071294) | 3.44688834 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.40057282 |
| 55 | response to interleukin-15 (GO:0070672) | 3.39448171 |
| 56 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.38239839 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.36789332 |
| 58 | response to host immune response (GO:0052572) | 3.36789332 |
| 59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.35688419 |
| 60 | regulation of RIG-I signaling pathway (GO:0039535) | 3.33658523 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33190181 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 3.33190181 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33190181 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33190181 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33190181 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 3.33190181 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32977727 |
| 68 | detection of external biotic stimulus (GO:0098581) | 3.30674867 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.30185983 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29817938 |
| 71 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.29280893 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.27723561 |
| 73 | * T cell migration (GO:0072678) | 3.27266487 |
| 74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.26180530 |
| 75 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26127306 |
| 76 | positive regulation of interleukin-12 production (GO:0032735) | 3.25616046 |
| 77 | mature B cell differentiation (GO:0002335) | 3.25348615 |
| 78 | regulation of hypersensitivity (GO:0002883) | 3.24297504 |
| 79 | respiratory burst (GO:0045730) | 3.24109680 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23610012 |
| 81 | dendritic cell differentiation (GO:0097028) | 3.20579340 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.19652382 |
| 83 | cellular response to interleukin-15 (GO:0071350) | 3.18952404 |
| 84 | defense response to protozoan (GO:0042832) | 3.18640069 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17117460 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13056107 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12108344 |
| 88 | response to host defenses (GO:0052200) | 3.11932914 |
| 89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11932914 |
| 90 | response to host (GO:0075136) | 3.11932914 |
| 91 | microglial cell activation (GO:0001774) | 3.11042627 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10964716 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 3.10110367 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08181550 |
| 95 | tolerance induction (GO:0002507) | 3.07339487 |
| 96 | interferon-gamma production (GO:0032609) | 3.06393609 |
| 97 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.06077243 |
| 98 | B cell mediated immunity (GO:0019724) | 3.05711216 |
| 99 | positive regulation of isotype switching (GO:0045830) | 3.05362658 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04218072 |
| 101 | cellular response to interferon-beta (GO:0035458) | 3.04155448 |
| 102 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02030357 |
| 103 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02030357 |
| 104 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00708019 |
| 105 | positive T cell selection (GO:0043368) | 3.00225464 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 2.99918676 |
| 107 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98713592 |
| 108 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.98073995 |
| 109 | positive regulation of T cell cytokine production (GO:0002726) | 2.97454332 |
| 110 | response to protozoan (GO:0001562) | 2.97278972 |
| 111 | detection of biotic stimulus (GO:0009595) | 2.97198728 |
| 112 | B cell homeostasis (GO:0001782) | 2.95799700 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.94821473 |
| 114 | natural killer cell activation (GO:0030101) | 2.94422808 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.92993555 |
| 116 | negative regulation of innate immune response (GO:0045824) | 2.92781127 |
| 117 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.92372039 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92176690 |
| 119 | negative regulation of phagocytosis (GO:0050765) | 2.91786697 |
| 120 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.91316925 |
| 121 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91018141 |
| 122 | germinal center formation (GO:0002467) | 2.90980548 |
| 123 | T-helper 1 type immune response (GO:0042088) | 2.90487218 |
| 124 | leukocyte mediated cytotoxicity (GO:0001909) | 2.89973120 |
| 125 | leukocyte cell-cell adhesion (GO:0007159) | 2.89174703 |
| 126 | T cell costimulation (GO:0031295) | 2.89116409 |
| 127 | regulation of necroptotic process (GO:0060544) | 2.89008053 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.88726479 |
| 129 | T cell proliferation (GO:0042098) | 2.85713587 |
| 130 | macrophage activation (GO:0042116) | 2.84386738 |
| 131 | lymphocyte costimulation (GO:0031294) | 2.83470792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.25049268 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.39316929 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.17963816 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.55187798 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.41157956 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.89212885 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60051462 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.58857667 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49131512 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.47450268 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34265715 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.31702266 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23112832 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18297794 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.00314084 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91276774 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.85144574 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.60458003 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57416818 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.51863818 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49275977 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.48611198 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.47334380 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37934381 |
| 25 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.32577900 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29973154 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.27535663 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16694751 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12551739 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12503634 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04515200 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04075902 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02411749 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97207423 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96822661 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95340657 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.90578433 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87518793 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76450459 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72699168 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72523065 |
| 42 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69462793 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67700064 |
| 44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63053988 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.57557565 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57204613 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55594419 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51290966 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42355701 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36149050 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35980149 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34638901 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33286596 |
| 54 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32720897 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32716108 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31579658 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30249287 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28658256 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28150970 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25148331 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24461621 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23974082 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23797193 |
| 64 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.21576556 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21367432 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20436598 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16198443 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13854113 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13738366 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13014884 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11395832 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09650627 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09239362 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09055349 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08790038 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05912660 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05257264 |
| 78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04767031 |
| 79 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04656398 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04125523 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03202630 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02055177 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01276120 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00630952 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98741236 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98623512 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97784479 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97742424 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96742694 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95169737 |
| 91 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92959370 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92146359 |
| 93 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90071556 |
| 94 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89573629 |
| 95 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88540336 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87872959 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86786583 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86306863 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83695629 |
| 100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.71180772 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71000501 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70768747 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66071476 |
| 104 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.64657572 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.64162731 |
| 106 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.63804108 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.62778403 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60868578 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60636243 |
| 110 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59758183 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59384251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.93229686 |
| 2 | MP0000685_abnormal_immune_system | 3.79337210 |
| 3 | MP0001790_abnormal_immune_system | 3.50643111 |
| 4 | MP0005387_immune_system_phenotype | 3.50643111 |
| 5 | MP0005671_abnormal_response_to | 3.43089366 |
| 6 | MP0001800_abnormal_humoral_immune | 3.30884529 |
| 7 | MP0003436_decreased_susceptibility_to | 3.27752260 |
| 8 | MP0009785_altered_susceptibility_to | 3.18496724 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.14918103 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.01451044 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.98260586 |
| 12 | MP0002723_abnormal_immune_serum | 2.85077969 |
| 13 | MP0005025_abnormal_response_to | 2.78683168 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.74000232 |
| 15 | MP0001819_abnormal_immune_cell | 2.73780509 |
| 16 | MP0002419_abnormal_innate_immunity | 2.70014952 |
| 17 | MP0004510_myositis | 2.69951907 |
| 18 | MP0003303_peritoneal_inflammation | 2.67885524 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.66977656 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.55947378 |
| 21 | MP0002398_abnormal_bone_marrow | 2.37140118 |
| 22 | MP0002006_tumorigenesis | 2.32979092 |
| 23 | MP0000716_abnormal_immune_system | 2.24312309 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.19174085 |
| 25 | MP0002405_respiratory_system_inflammati | 2.16978467 |
| 26 | MP0006082_CNS_inflammation | 2.06074680 |
| 27 | MP0001873_stomach_inflammation | 1.95366033 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.94842019 |
| 29 | MP0005310_abnormal_salivary_gland | 1.93091805 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.90441634 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.88405798 |
| 32 | MP0004947_skin_inflammation | 1.88137346 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.87607171 |
| 34 | MP0001853_heart_inflammation | 1.85179333 |
| 35 | MP0002722_abnormal_immune_system | 1.84777016 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.84668275 |
| 37 | MP0002429_abnormal_blood_cell | 1.83358293 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.76770769 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.76367840 |
| 40 | MP0003724_increased_susceptibility_to | 1.71880375 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.61649877 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.52776579 |
| 43 | MP0005451_abnormal_body_composition | 1.50470657 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.48437839 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.44694553 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.44694553 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.44202024 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.41795800 |
| 49 | MP0001348_abnormal_lacrimal_gland | 1.38048875 |
| 50 | MP0003448_altered_tumor_morphology | 1.38028706 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.37704581 |
| 52 | MP0008260_abnormal_autophagy | 1.37321742 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.36665913 |
| 54 | MP0008469_abnormal_protein_level | 1.35544108 |
| 55 | MP0002163_abnormal_gland_morphology | 1.31756317 |
| 56 | MP0002933_joint_inflammation | 1.29092504 |
| 57 | MP0002009_preneoplasia | 1.28999510 |
| 58 | MP0002254_reproductive_system_inflammat | 1.28262193 |
| 59 | MP0003866_abnormal_defecation | 1.27855660 |
| 60 | MP0009278_abnormal_bone_marrow | 1.26725846 |
| 61 | MP0000858_altered_metastatic_potential | 1.23312821 |
| 62 | MP0008057_abnormal_DNA_replication | 1.20742549 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.16933168 |
| 64 | MP0009764_decreased_sensitivity_to | 1.09956752 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.04165147 |
| 66 | MP0000490_abnormal_crypts_of | 1.03402556 |
| 67 | MP0010307_abnormal_tumor_latency | 1.00286462 |
| 68 | MP0002132_abnormal_respiratory_system | 0.97809142 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.96672355 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.94867965 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.94507273 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.92005923 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.89992772 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.89462238 |
| 75 | MP0003690_abnormal_glial_cell | 0.87689139 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.85985276 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.83112739 |
| 78 | MP0000371_diluted_coat_color | 0.77951109 |
| 79 | MP0001851_eye_inflammation | 0.77858630 |
| 80 | MP0004883_abnormal_blood_vessel | 0.77529350 |
| 81 | MP0003091_abnormal_cell_migration | 0.77406807 |
| 82 | MP0009763_increased_sensitivity_to | 0.75662574 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.74692483 |
| 84 | MP0003045_fibrosis | 0.74422974 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.73661695 |
| 86 | MP0008004_abnormal_stomach_pH | 0.72932558 |
| 87 | MP0009840_abnormal_foam_cell | 0.69114127 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.67930228 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.67350650 |
| 90 | MP0000343_altered_response_to | 0.65193290 |
| 91 | MP0000604_amyloidosis | 0.65135923 |
| 92 | MP0005164_abnormal_response_to | 0.61225231 |
| 93 | MP0000249_abnormal_blood_vessel | 0.60934021 |
| 94 | MP0008874_decreased_physiological_sensi | 0.59572799 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.58864151 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.58376094 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.57219721 |
| 98 | MP0001663_abnormal_digestive_system | 0.56846280 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.56789902 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.55860896 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55255887 |
| 102 | MP0005390_skeleton_phenotype | 0.54145963 |
| 103 | MP0003077_abnormal_cell_cycle | 0.53164177 |
| 104 | MP0000313_abnormal_cell_death | 0.52403778 |
| 105 | MP0003075_altered_response_to | 0.50820916 |
| 106 | MP0000609_abnormal_liver_physiology | 0.49041739 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.48851500 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.48760645 |
| 109 | MP0005166_decreased_susceptibility_to | 0.48464601 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.48415704 |
| 111 | MP0005621_abnormal_cell_physiology | 0.47532694 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.46806928 |
| 113 | MP0003795_abnormal_bone_structure | 0.46781420 |
| 114 | MP0003828_pulmonary_edema | 0.46596007 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.46282357 |
| 116 | MP0001346_abnormal_lacrimal_gland | 0.45942669 |
| 117 | MP0004381_abnormal_hair_follicle | 0.45877557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.83684644 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.66073947 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.42186204 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.95086447 |
| 5 | Recurrent viral infections (HP:0004429) | 4.91428194 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.48912091 |
| 7 | Myositis (HP:0100614) | 4.47804919 |
| 8 | Chronic otitis media (HP:0000389) | 4.43637530 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.37472951 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.28199927 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.00436116 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.00436116 |
| 13 | Recurrent skin infections (HP:0001581) | 3.99740280 |
| 14 | Vasculitis (HP:0002633) | 3.90765811 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.90602210 |
| 16 | Optic neuritis (HP:0100653) | 3.90602210 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.88808990 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.86724569 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84918194 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.80859121 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.79896404 |
| 22 | Meningitis (HP:0001287) | 3.71499968 |
| 23 | Orchitis (HP:0100796) | 3.70604531 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.70534035 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.62803250 |
| 26 | Nasal polyposis (HP:0100582) | 3.56983440 |
| 27 | IgM deficiency (HP:0002850) | 3.48304262 |
| 28 | Cellulitis (HP:0100658) | 3.46178481 |
| 29 | T lymphocytopenia (HP:0005403) | 3.45596338 |
| 30 | Obstructive lung disease (HP:0006536) | 3.44987930 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44987930 |
| 32 | Thrombocytosis (HP:0001894) | 3.40447893 |
| 33 | Inflammation of the large intestine (HP:0002037) | 3.39633486 |
| 34 | Colitis (HP:0002583) | 3.35272406 |
| 35 | Abnormality of T cells (HP:0002843) | 3.32305303 |
| 36 | Increased IgM level (HP:0003496) | 3.31615921 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.27562868 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 3.26913928 |
| 39 | Stomatitis (HP:0010280) | 3.25754993 |
| 40 | Eosinophilia (HP:0001880) | 3.19348112 |
| 41 | Periodontitis (HP:0000704) | 3.10515192 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 3.08637610 |
| 43 | Leukocytosis (HP:0001974) | 3.07289080 |
| 44 | Gingivitis (HP:0000230) | 3.07114069 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 3.03510137 |
| 46 | Pustule (HP:0200039) | 3.02441826 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98789236 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.95109415 |
| 49 | Lymphopenia (HP:0001888) | 2.93950014 |
| 50 | Arterial thrombosis (HP:0004420) | 2.92452870 |
| 51 | Granulocytopenia (HP:0001913) | 2.88804369 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.87507007 |
| 53 | Increased IgE level (HP:0003212) | 2.87411486 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.84985232 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.84345932 |
| 56 | Hemoptysis (HP:0002105) | 2.75302106 |
| 57 | IgG deficiency (HP:0004315) | 2.72309428 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.69841671 |
| 59 | Encephalitis (HP:0002383) | 2.66140594 |
| 60 | B lymphocytopenia (HP:0010976) | 2.65611220 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.65611220 |
| 62 | IgA deficiency (HP:0002720) | 2.64942518 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.62760070 |
| 64 | Chronic sinusitis (HP:0011109) | 2.62677039 |
| 65 | Gingival bleeding (HP:0000225) | 2.58547424 |
| 66 | Osteomyelitis (HP:0002754) | 2.58334951 |
| 67 | Thyroiditis (HP:0100646) | 2.57516990 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.57140515 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.56333235 |
| 70 | Chronic diarrhea (HP:0002028) | 2.49137115 |
| 71 | Chest pain (HP:0100749) | 2.48614402 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.47479548 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.46728392 |
| 74 | Fatigue (HP:0012378) | 2.46485900 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.46211946 |
| 76 | Emphysema (HP:0002097) | 2.45759239 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.42551923 |
| 78 | Basal ganglia calcification (HP:0002135) | 2.38367182 |
| 79 | Verrucae (HP:0200043) | 2.37865439 |
| 80 | Papilloma (HP:0012740) | 2.37865439 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.37782717 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.36502545 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.36345512 |
| 84 | Pulmonary embolism (HP:0002204) | 2.33586554 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.33253510 |
| 86 | Viral hepatitis (HP:0006562) | 2.32604045 |
| 87 | Gangrene (HP:0100758) | 2.27688120 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.26379255 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25661619 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25661619 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25661619 |
| 92 | Epistaxis (HP:0000421) | 2.24758628 |
| 93 | Petechiae (HP:0000967) | 2.22821201 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.22274231 |
| 95 | Joint swelling (HP:0001386) | 2.21981491 |
| 96 | Urticaria (HP:0001025) | 2.21746331 |
| 97 | Skin ulcer (HP:0200042) | 2.21646585 |
| 98 | Episodic fever (HP:0001954) | 2.20498812 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.18597405 |
| 100 | Hematochezia (HP:0002573) | 2.16630251 |
| 101 | Increased serum ferritin (HP:0003281) | 2.15718246 |
| 102 | Anorexia (HP:0002039) | 2.13500709 |
| 103 | Purpura (HP:0000979) | 2.13372879 |
| 104 | Hypochromic anemia (HP:0001931) | 2.10466078 |
| 105 | Myocardial infarction (HP:0001658) | 2.10161174 |
| 106 | Loss of speech (HP:0002371) | 2.09664765 |
| 107 | Lymphoma (HP:0002665) | 2.07576502 |
| 108 | Restrictive lung disease (HP:0002091) | 2.07227667 |
| 109 | Abnormality of the prostate (HP:0008775) | 2.06949642 |
| 110 | Sepsis (HP:0100806) | 2.06440918 |
| 111 | Prolonged bleeding time (HP:0003010) | 2.06353868 |
| 112 | Bronchitis (HP:0012387) | 2.06129165 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.04696559 |
| 114 | Arthralgia (HP:0002829) | 2.03960899 |
| 115 | Leukopenia (HP:0001882) | 2.02343069 |
| 116 | Amaurosis fugax (HP:0100576) | 1.98655680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.62324201 |
| 2 | MAP3K14 | 4.23230818 |
| 3 | PRPF4B | 3.69974873 |
| 4 | TYK2 | 3.58237702 |
| 5 | JAK3 | 3.43764133 |
| 6 | TBK1 | 2.86043308 |
| 7 | BLK | 2.85266072 |
| 8 | MAP3K13 | 2.79755677 |
| 9 | TXK | 2.72800064 |
| 10 | IRAK4 | 2.68629307 |
| 11 | IKBKE | 2.62851520 |
| 12 | RIPK4 | 2.60529424 |
| 13 | IKBKB | 2.58513675 |
| 14 | JAK1 | 2.38021981 |
| 15 | KIT | 2.23617288 |
| 16 | ZAP70 | 1.99489688 |
| 17 | SYK | 1.92705384 |
| 18 | BTK | 1.88039549 |
| 19 | CSF1R | 1.82701812 |
| 20 | CHUK | 1.75255353 |
| 21 | STK10 | 1.72547025 |
| 22 | IRAK3 | 1.67660034 |
| 23 | GRK6 | 1.61661948 |
| 24 | ITK | 1.48714658 |
| 25 | LCK | 1.47795895 |
| 26 | FGFR4 | 1.47767519 |
| 27 | TEC | 1.47438232 |
| 28 | CSK | 1.47013592 |
| 29 | HCK | 1.43011055 |
| 30 | MAP3K10 | 1.38844154 |
| 31 | EPHB1 | 1.37779296 |
| 32 | SIK2 | 1.33682671 |
| 33 | TAOK3 | 1.27651018 |
| 34 | FES | 1.25924845 |
| 35 | PIM1 | 1.21950714 |
| 36 | FGFR3 | 1.20740126 |
| 37 | NEK9 | 1.18572477 |
| 38 | SMG1 | 1.18150212 |
| 39 | TAOK2 | 1.17214154 |
| 40 | FLT3 | 1.12315382 |
| 41 | LYN | 1.09618361 |
| 42 | PIM2 | 1.08933910 |
| 43 | LRRK2 | 1.08809321 |
| 44 | JAK2 | 1.07137569 |
| 45 | TAOK1 | 1.06946645 |
| 46 | CLK1 | 1.02712624 |
| 47 | ERN1 | 1.01945864 |
| 48 | MAP3K3 | 0.97880654 |
| 49 | MST4 | 0.94874546 |
| 50 | RPS6KA4 | 0.94776042 |
| 51 | EEF2K | 0.92960457 |
| 52 | MAP3K1 | 0.92577781 |
| 53 | MARK3 | 0.91929325 |
| 54 | NLK | 0.91015701 |
| 55 | CDC42BPA | 0.88162355 |
| 56 | PRKCQ | 0.86555513 |
| 57 | STK4 | 0.86187045 |
| 58 | CDK12 | 0.84648491 |
| 59 | SIK3 | 0.82031756 |
| 60 | MAP2K3 | 0.78171053 |
| 61 | EPHA3 | 0.77432541 |
| 62 | MAPK12 | 0.70385920 |
| 63 | NME2 | 0.70111333 |
| 64 | MARK2 | 0.67704634 |
| 65 | MAPK7 | 0.66991878 |
| 66 | FGR | 0.66541796 |
| 67 | PASK | 0.63996770 |
| 68 | TTN | 0.62398274 |
| 69 | PTK6 | 0.60473049 |
| 70 | GRK7 | 0.60232877 |
| 71 | PDPK1 | 0.58405351 |
| 72 | IRAK2 | 0.58052019 |
| 73 | TRPM7 | 0.56518561 |
| 74 | KSR2 | 0.54676137 |
| 75 | TRIB3 | 0.54143296 |
| 76 | TESK2 | 0.54030004 |
| 77 | TGFBR2 | 0.52446453 |
| 78 | MAPKAPK2 | 0.52300738 |
| 79 | PKN1 | 0.51551768 |
| 80 | CDK4 | 0.51396674 |
| 81 | PKN2 | 0.49249314 |
| 82 | PRKD2 | 0.49146223 |
| 83 | CAMKK1 | 0.48970194 |
| 84 | IRAK1 | 0.48255288 |
| 85 | ABL1 | 0.46014672 |
| 86 | NEK2 | 0.44585270 |
| 87 | PRKCD | 0.44569124 |
| 88 | KDR | 0.43032596 |
| 89 | RPS6KA6 | 0.41585538 |
| 90 | TNK2 | 0.40640073 |
| 91 | PRKAA2 | 0.40547393 |
| 92 | MAP3K5 | 0.39833752 |
| 93 | EIF2AK2 | 0.39415281 |
| 94 | EGFR | 0.38860567 |
| 95 | MAP3K8 | 0.38608129 |
| 96 | CDK6 | 0.38503801 |
| 97 | SIK1 | 0.38046959 |
| 98 | CAMKK2 | 0.37558015 |
| 99 | BMPR2 | 0.35615650 |
| 100 | HIPK2 | 0.33841289 |
| 101 | STK24 | 0.33098393 |
| 102 | PIK3CG | 0.32898446 |
| 103 | PDK1 | 0.32643724 |
| 104 | MAP3K7 | 0.32250739 |
| 105 | MOS | 0.31938499 |
| 106 | YES1 | 0.31101559 |
| 107 | ALK | 0.29658067 |
| 108 | MELK | 0.29585644 |
| 109 | RPS6KA5 | 0.29415573 |
| 110 | CDK19 | 0.28731010 |
| 111 | ATR | 0.28293911 |
| 112 | RPS6KL1 | 0.28288976 |
| 113 | RPS6KC1 | 0.28288976 |
| 114 | BRD4 | 0.27865350 |
| 115 | MATK | 0.27022764 |
| 116 | PRKCH | 0.25350371 |
| 117 | MAPK3 | 0.24391098 |
| 118 | BMX | 0.24378149 |
| 119 | MAP3K11 | 0.24275634 |
| 120 | FYN | 0.23390515 |
| 121 | RAF1 | 0.22775481 |
| 122 | MAPK4 | 0.22367782 |
| 123 | RPS6KA1 | 0.22327669 |
| 124 | CDK9 | 0.21616311 |
| 125 | MAPK11 | 0.21502534 |
| 126 | ACVR1B | 0.21488363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25969314 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.07750780 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.01320613 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90304851 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87060867 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.82870419 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.59051697 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48642202 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35298742 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24327641 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.20117909 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.14863981 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14252957 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14226967 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13232583 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.95563354 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91115329 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88772046 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85244994 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78020005 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74591629 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73682625 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.73330772 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69816220 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.65902646 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.62893567 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62614873 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62369033 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.61703326 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60464572 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.54147218 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53469006 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.47279549 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.41962877 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.41666123 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40333401 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.30161255 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28348120 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28025546 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27262093 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26825583 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09539743 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09517150 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07008829 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.06903037 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03923207 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.01667441 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01232768 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92216773 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89618883 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88645526 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86850383 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84714256 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84354518 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78890153 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.77691419 |
| 57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76742691 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76572867 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76483999 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.73523373 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69336555 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67847021 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66423705 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65759016 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.61452277 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.59489891 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56976542 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.56707791 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54772665 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53963303 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50438559 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48668243 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45645689 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44888528 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44330101 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42732173 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41156790 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40002178 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39809090 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39290717 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.38328125 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37824273 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37646543 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37475415 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36514615 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36398169 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36393932 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.34262308 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33707775 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32840383 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32590936 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31969050 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.30259180 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.29090577 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.28937325 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28669533 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24286038 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23866456 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23343580 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23180626 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.22372939 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21999802 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21603050 |
| 104 | Ribosome_Homo sapiens_hsa03010 | 0.21236898 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21077798 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.19585072 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.18910081 |
| 108 | Mismatch repair_Homo sapiens_hsa03430 | 0.18838122 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18769135 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18549541 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17298815 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17017965 |

